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Abstract The skin constitutes a formidable barrier against
commensal and pathogenic bacteria, which permanently and
transiently colonise the skin, respectively. Commensal and
pathogenic species inhabiting skin both express proteases.
Whereas proteases secreted by commensals contribute to
homeostatic bacterial coexistence on skin, proteases from
pathogenic bacteria are used as virulence factors, helping
them colonise skin with breached integrity of the epithelial
layer. From these initial sites of colonisation, pathogens can
disseminate into deeper layers of skin, possibly leading to
the spread of infection. Secreted bacterial proteases proba-
bly play an important role in this process and in the deter-
rence of innate defence mechanisms. For example,
Staphylococcus aureus proteases are essential for changing
the bacterial phenotype from adhesive to invasive by
degrading adhesins on the bacterial cell surface. Secreted
staphylococcal proteases mediate pathogen penetration by
degrading collagen and elastin, essential components of
connective tissue in the dermis. The activation of the contact
system and kinin generation by Streptococcus pyogenes and
S. aureus proteases contributes to an inflammatory reaction
manifested by oedema, redness and pain. Kinin-enhanced
vascular leakage might help bacteria escape into the circu-
lation thereby causing possible systemic dissemination of
the infection. The inflammatory reaction can also be fueled
by the activation of protease-activated receptors on kerati-
nocytes. Concomitantly, bacterial proteases are involved in
degrading antimicrobial peptides, disarming the comple-
ment system and neutrophils and preventing the infiltration
of the infected sites with immune cells by inactivation of
chemoattractants. Together, this provides protection for col-
onising and/or invading pathogens from attack by antibac-
terial forces of the skin.
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Skin: structure and function
Skin is the largest organ in the body and acts as a physical
barrier against the external environment. In addition to
protecting the body against microorganisms, ultraviolet ra-
diation, toxins, allergens or mechanical insults, skin also
regulates the transport of water, electrolytes and some sup-
plements, plus body temperature and metabolism. Skin has
four structural layers: the epidermis, basement membrane,
dermis and a fat layer, also called the subcutaneous layer
(subcutis).
The epidermis, the outer layer of skin, is a dynamic
structure composed of keratinocytes, melanocytes, Langer-
hans cells and Merkel cells. The mature human epidermis
consists in four layers (from the innermost layer to the
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surface): the stratum basale (SB), stratum spinosum (SS),
stratum granulosum (SG) and stratum corneum (SC). The
SB, which lies adjacent to the dermis, comprises mainly
dividing undifferentiated keratinocytes, which are attached
to the basement membrane by hemidesmosomes. Scattered
throughout the basal layer of the epidermis are pigment
(melanin)-producing melanocytes. Merkel cells are also
found in the basal layer in large numbers at touch-sensitive
sites, such as the fingertips and lips. They are closely asso-
ciated with cutaneous nerves and seem to be involved in
light touch sensation. As basal keratinocytes move towards
the outer layer of skin, they become connected by desmo-
somes, initially forming the SS and then they undergo
terminal differentiation at the SG and SC layers (Kawakubo
et al. 2011). The keratinocyte plasma membrane is replaced
with an insoluble protein envelope, inducing aggregation of
keratin intermediate filaments via filaggrin. The collapse of
their cytoskeleton into flattened squames and the orientation
of the keratin proteins add strength to the SC. The resulting
non-viable cornifed cells, known as corneocytes and sur-
rounded by lipids, provide the natural physical and water-
retaining barrier of the skin (Candi et al. 2005). In most
areas of the skin, there are 10-30 layers of dead cells. During
terminal differentiation and cornification, granular keratino-
cytes secrete structural and adhesion proteins, lipids, anti-
microbial peptides (AMPs), proteases and their inhibitors
via lamellar granules into the extracellular space.
The dermis is the deepest layer of the skin and provides
structural support for the skin. This layer is anchored to the
epithelium by the basement membrane, a multilayered struc-
ture forming the dermo-epidermal junction. The dermis con-
sists in fibroblasts, which produce collagen, elastin, fibrillin
and structural proteoglycans, together with immunocompetent
mast cells and macrophages. Collagen fibers constitute 70%
of the dermis, providing strength and toughness. Elastin main-
tains normal elasticity and flexibility, whereas proteoglycans
provide viscosity and hydration. The fibrous tissue of the
dermis anchors blood and lymphatic vessels, nervous cells
and fibers, sweat and sebaceous glands, follicles and small
quantities of striated muscle. The subcutis or hypodermis,
which is made up of a loose connective tissue layer and is
an important depot of fat, lies below the dermis.
Immune components of the skin
Apart from acting as a physical barrier between the host and
the environment, the skin also plays a key immunological role
in sensing and responding to invading pathogens. The skin
immune system can provide early innate immune responses,
which promote cutaneous inflammation and adaptive immune
responses that lead to an immunological memory that can
recognise foreign antigens (Kupper and Fuhlbrigge 2004). A
network of endogenous proteolytic enzymes and their inhib-
itors play an important role in this process (Yoshida 2010;
Blaber et al. 2010; Beaufort et al. 2010; Sotiropoulou and
Pampalakis 2010; Ohler et al. 2010).
The constitutive innate immune mechanisms in the skin
consist in (1) commensal microorganisms that occupy
niches suitable for bacterial growth and (2) the corneal layer
comprised of dead keratinocytes and providing the physical
barrier of the skin and chemical defence in the form of
AMPs. In humans, such peptides include β-defensin 2, β-
defensin 3, cathelicidin and RNase 7, which are induced in
response to infection and exert bacteriostatic or bactericidal
activity against invading pathogens (Schauber and Gallo
2009). Keratinocytes that compose the deeper layers of the
skin (granular, spinous and basal layers) express pattern
recognition receptors. These include Toll-like receptors
and nucleotide-binding oligomerisation domain proteins,
which sense the pathogen-associated molecular patterns of
invading microorganisms and initiate early cutaneous im-
mune responses (Kawai and Akira 2010). In addition to
keratinocytes, other cells contribute to the cutaneous im-
mune responses, including Langerhans cells and γδ T cells
(mice only) in the epidermis, plus macrophages, dendritic
cells, mast cells, B and T cells, plasma cells, natural killer
cells and fibroblasts in the dermis (Wehner et al. 2011;
Tobin et al. 2011; Kupper and Fuhlbrigge 2004).
Microflora of the skin
The skin is a habitat for commensal bacteria, including
Staphylococcus, Micrococcus and Corynebacterium sp.,
which act as a barrier against colonisation by potentially
pathogenic microbes and any overgrowth of opportunistic
pathogens already present on the skin. Protection is exerted
passively by depleting available nutrients for competing
bacteria and by preventing their adherence and/or transloca-
tion across skin layers. Invaders are also actively deterred by
bacteriocin (e.g. epidermin, Pep5 and epilancin K7, bacter-
iocins secreted by S. epidermidis; Bastos et al. 2009) and
toxic metabolites produced by commensal microflora. Fi-
nally, the pathogenicity of invading species can be tempered
by degradation of their virulence factors via proteases re-
leased by commensals. In addition to providing direct pro-
tection against pathogens, commensals promote endogenous
antibacterial activity by stimulating the production of AMPs
via keratinocytes and by enhancing the antibody production
of immune cells and bacterial clearance by local phagocytes.
Commensals also help maintain inflammatory homeostasis
by suppressing excess cytokine release after minor epider-
mal injury.
Apart from benign commensals, the human skin is often
colonised by opportunistic pathogens. Among them,
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Staphylococcus aureus and Streptococcus pyogenes are the
most common species. Because of the frequency of these
Gram-positive bacteria on healthy skin, S. aureus and S.
pyogenes are sometimes considered to be part of the normal
bacterial flora of the skin. This is not the case for Gram-
negative organisms such as Pseudomonas aeruginosa, Pas-
teurella multocida, Capnocytophaga canimorsus, Bartonella
sp., Klebsiella rhinoscleromatis and Vibrio vulnificus, which
are never found in the normal microflora of healthy skin and
are responsible for cutaneous infections (Chiller et al. 2001).
Bacterial proteases in the skin
A variety of proteases are expressed by skin microflora,
including enzymes produced by commensal species that
sustain habitat homeostasis and those exploited and used
as powerful virulence factors by pathogens during infection
and skin injury (Fig. 1, Table 1).
Role of proteases in survival and colonisation
Commensal skin microflora and pathogenic species are both
well equipped with factors that promote colonisation and
persistence in the harsh conditions of the skin. A crucial step
that ensures successful colonisation is bacterial adherence to
the horny epidermal layer. S. aureus express a distinct array of
receptors that recognise different human extracellular matrix
proteins. These receptors are termed “microbial surface com-
ponents recognising adhesive matrix molecules”
(MSCRAMMs; Patti et al. 1994; Foster and Hook 1998).
Microbial cell surface proteins are important virulence factors
and specifically bind to extracellular matrix proteins such as
fibronectin (fibronectin-binding proteins, FNBPA and
FNBPB), fibrinogen (clumping factors, such as ClfA and
ClfB) and collagen (collagen-binding protein). They are
expressed in a coordinated and sequential fashion that
depends on bacterial cell density. Regulatory loci, such as
accessory gene regulator (agr) and staphylococcal accessory
regulator (sar), coordinate the gene expression of most S.
aureus MSCRAMMs and secreted proteins (Novick 2003).
S. aureus adhesins are expressed during the early exponential
growth phase, when bacterial cell density is low, whereas
hemolysins, toxins and enzymes facilitating tissue destruction
and dissemination, including proteases, are expressed at the
end of the exponential phase and during the stationary phase
of growth (Pragman and Schlievert 2004). During colonisa-
tion, staphylococcal proteases play an important role by con-
trolling the stability and/or processing of cell surface proteins.
One clear example is the proteolysis of FNBP by Ssp (V8), a
staphylococcal serine protease, which decreases the adhesive
phenotype of S. aureus and allows dissemination of the
pathogen (McGavin et al. 1997).
The current paradigm suggests that tissue colonisation
occurs via the formation of multicellular surface-attached
agglomerations of microorganisms called “biofilm”. Prima-
ry attachment of bacteria to the surface and subsequent
aggregation can initiate biofilm formation, which provides
resistance against many antibiotics and host defence mech-
anisms. In the mature biofilm, channels are formed for
nutrient delivery to all biofilm cells, whereas the detachment
of cell clusters can lead to the dissemination of infection.
Distractive forces are crucial for both these aspects (O'Toole
et al. 2000). Intracellular aggregation in biofilm is mediated
by a variety of surface macromolecules, including proteins.
Several lines of evidence indicate that S. aureus proteases
are involved in the enzymatic degradation of proteinaceous
biofilm formation supporting factors (Boles and Horswill
2008). The activity of S. aureus extracellular proteases,
including the metalloprotease aureolysin (Aur) and Spl pro-
tease, has been demonstrated to be required for agr-mediat-
ed detachment in established biofilms. The targets of these
agr-controlled proteases are not known but surface adhesins
are likely substrates. Candidates include the surface proteins
Atl, Bap and SasG, all of which play significant roles in
biofilm formation (Corrigan et al. 2007; Trotonda et al.
2005; Cucarella et al. 2001; Biswas et al. 2006). Recently,
the Bap protein has been identified as an Aur and SspA
substrate (Martí et al. 2010). Atl is additionally known to
require proteolytic processing for activation, which is
inhibited by phenylmethylsulfonyl fluoride (Oshida et al.
1995). As described earlier, other possible targets of staphy-
lococcal proteases include MSCRAMMs, which are impor-
tant for adherence to the extracellular matrices of
mammalian cells. Finally, the activation of lipase (Sal-1
and Sal-2) precursors by proteases secreted by S. aureus
and the proteolytic processing of staphylococcal
nucleases (Gotz et al. 1998; Suciu and Inouye 1996;
Davis et al. 1977) might contribute to S. aureus dispersal
and colonisation of new sites.
S. epidermidis, a common bacterial coloniser of mamma-
lian skin, also produces exoproteases, namely cysteine (Ecp)
and serine (Esp) proteases with relatively low substrate
specificity (Dubin et al. 2001). The cysteine protease from
S. epidermidis possesses the ability to cleave fibrinogen and
fibronectin (Oleksy et al. 2004). Although Ecp and/or Esp
have not been reported to contribute to S. epidermidis de-
tachment from biofilm, these findings collectively indicate a
significant contribution of proteases to bacterial dissemination
via proteolytic inactivation of adhesive molecules.
The commensal lifestyle of S. epidermidis is partly
achieved by the expression of the extracellular neutral metal-
loprotease SepA, which efficiently inactivates anionic AMP
dermcidin (Lai et al. 2007). As part of the human skin micro-
flora, S. epidermidis plays a probiotic function by preventing
colonisation of more pathogenic bacteria such as S. aureus.
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One can argue that the SepA protease-mediated proteolytic
degradation of AMP, a major determinant of innate host
defence, creates a safe niche for dermicidin susceptible patho-
gens. Nevertheless, no evidence exists showing that S. epi-
dermidis proteases facilitate the colonisation of the skin by
other microorganisms in vivo.
S. epidermidis is a good example of the dependency of
successful bacterial colonisation of the skin on the deter-
rence of AMP bactericidal activity. In the skin, AMPs are
produced mainly by keratinocytes, neutrophils, sebocytes or
sweat glands and are either expressed constitutively or after
an inflammatory stimulus (Gallo and Nakatsuji 2011). In
addition to exerting strong bactericidal potential by disrupt-
ing bacterial cell membranes, they can also act as potent
immunomodulators. The function of defensins and catheli-
cidins, the best-characterised AMPs, is potentiated by
AMPs derived from complement (Frick et al. 2006; Nordahl
et al. 2004), haemoglobin (Mak 2008), serine proteases
(Kasetty et al. 2011) or kininogen (Nordahl et al. 2005).
Throughout evolution, microorganisms have developed
many strategies to disable AMPs, one of them being pro-
teolytic degradation. Despite the finding that AMPs are
relatively resistant to proteolytic degradation, many skin
pathogens produce proteases that can degrade human cath-
elicidins. Aureolysin, a metalloprotease of S. aureus,
cleaves and inactivates LL-37, which might be the reason
that highly proteolytic S. aureus strains are resistant to
cathelicidin (Sieprawska-Lupa et al. 2004). S. aureus is not
Fig. 1 Representation of some bacterial protease targets in the skin.
Bacterial proteases (right) contribute to skin colonisation by microor-
ganisms by providing nutrients and by modulating bacterial adherence
properties. In epidermis, bacterial proteases can neutralise antibacterial
peptides (antimicrobial peptides [AMPs], such as LL37), creating a safe
niche for AMP-susceptible pathogens. The disruption of desmosomal
kadherins (desmoglein 1), which provide cell-cell adhesion, causes exfo-
liation in the stratum granulosum. Bacterial proteolytic activity induces
protease-activated receptor (PAR) signalling involved in cutaneous in-
flammation. Pathogen penetration is facilitated by degradation of colla-
gen and elastin, essential components of connective tissue of the dermis,
by secreted bacterial proteases. Proteases produced by skin bacteria
modulate the skin immune system. Professional phagocyte functions are
disabled upon bacterial proteases. Proteases may also lead to the depletion
of functional neutrophils at infection sites, thus facilitating pathogen
colonisation and spreading in subepithelial tissues. The cleaving of anti-
bodies by bacterial proteases leads to the avoidance of an immunological
response. Bacterial proteases target and subvert the complement system
by degrading or binding complement components to prevent activation of
the pathway. As potent activators of the contact system, bacterial pro-
teases may participate in the uncontrolled generation of proinflammatory
mediators, inducing an excessive inflammatory reaction, which can lead
to serious tissue damage (Subcut. subcutaneous). Figures were produced
using Servier Medical Art
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the sole pathogen that has evolved such a strategy. S. pyo-
genes is also well protected against LL-37 through an intri-
cate mechanism involving streptopain (SpeB) expression.
SpeB, an extracellular enzyme, is concentrated in the prox-
imity of the bacterial cell membrane in a complex with an α-
2-macroglobulin (α2M) immobilised on the streptococcal
cell surface by interacting with the GRAB protein. Despite
being entrapped by α2M, the enzyme is still proteolytically
active against peptides, including LL-37. To reach the cell
membrane, LL-37 must penetrate a layer of the α2M-strep-
topain complex coating the bacterium where it is proteolyt-
ically degraded, allowing S. pyogenes to resist AMPs.
Indeed, SpeB has unambiguously been demonstrated to
contribute to streptococcal resistance against LL-37 in vivo
in patients with severe S. pyogenes infections of soft tissue
(Johansson et al. 2008). Similarly, the colonisation of chron-
ic ulcers by P. aeruginosa, E. faecalis and P. mirabilis might
be related to the proteolytic inactivation of LL-37 by elas-
tase, gelatinase and metalloprotease (ZapA), respectively
(Schmidtchen et al. 2002). The degradation of LL-37 by a
subtilisin-like serine protease of Finegoldia magna (formerly
Peptostreptococcus magnus), a commensal bacterium colo-
nising human skin and mucous membranes, has also been
documented (Karlsson et al. 2007).
The evolutionary adaptation of S. aureus and S. epidermi-
dis, inhabitants of healthy human skin, to this organ chemical
defence is manifested by sensing dermicidin. In response to
dermicidin, the extracellular proteolytic activity of staphylo-
cocci is enhanced, resulting in proteolytic degradation of
dermicidin and bacterial resistance to this antibacterial peptide
(Lai et al. 2007). Since bacterial proteases can inactivate the
most important chemical antimicrobial barrier in skin, namely
AMPs, further invasion and penetration into the deeper skin
layers is highly likely. Nevertheless, it must be stressed that
none of the bacteria can penetrate intact skin and cause infec-
tion unaided. However, once the integrity of the epidermis is
compromised by cuts, wounds, burns, abrasions or bites,
bacterial proteases released from colonising pathogens can
significantly deter the immune system and lead to further
tissue damage and to bacterial dissemination and infection.
Tissue damage/injury
Bacterial proteases possess a propensity to destroy host
tissue by two distinct mechanisms: direct breakage of the
skin barrier, which occurs by cleavage of structural proteins
in the skin, or indirect damage, which occurs following an
excessive induction of the inflammatory response.
Direct mechanism of proteases action
S. aureus secretes exfoliative toxins, known as epidermo-
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and staphylococcal scaled-skin syndrome (SSSS). Staphy-
lococcal scalded skin syndrome is a disease that predomi-
nantly affects infants and is characterised by the loss of
superficial skin layers, dehydration and secondary infec-
tions. The toxin is a serine protease of ~30 kDa character-
ised by a narrow substrate specificity. ET recognises and
cleaves only desmoglein 1, a desmosomal cadherin that
mediates cell–cell adhesion (Amagai et al. 2002; Hanakawa
et al. 2004). The target protein, desmoglein 1, is recognised
both through an interaction at the classical P1 site and via
additional features in the tertiary structure, located away
from the hydrolysed peptide bond. Disruption of desmo-
glein 1 by ETs in the deep layers of skin can be compensated
by another desmoglein, desmoglein 3. Therefore, exfoliation
only occurs in the SG, in which desmoglein 3 is not present.
Accordingly, the hydrolysis of desmoglein 1 (but not that of
other desmogleins) by ETs has been demonstrated experi-
mentally both in vitro and in vivo, thus elucidating the
mechanism of ET-induced epidermolysis (Amagai et al.
2000; Hanakawa et al. 2002). The toxin can spread through
the bloodstream and therefore not all lesions are infected.
Overall, the destruction of the epidermal barrier facilitates
efficient progression of the infection. Three exfoliative tox-
ins (ET), namely A, B and D, encoded by eta, etb and etd,
respectively, have been identified (Lee et al. 1987). ETA-
producing strains dominate Europe, USA and Africa (de
Azavedo and Arbuthnott 1981). Expression of both eta
and etb is regulated by agr (Sheehan et al. 1992).
The S. aureus extracellular serine protease, glutamylen-
dopeptidase SspA, commonly referred to as V8 protease, is
also regulated by the agr system. SspA preferentially
cleaves peptide bonds with glutamate (and aspartate, to a
lesser extent) at the carboxy-terminal side (Ono et al. 2010).
Interestingly, the SspA protease shows sequence similarity
to exfoliative toxins and shares a similar specificity of
glutamate-specific cleavage (Dubin 2002). Recently, SspA
has been reported to impair the epidermal permeability
barrier in nude mice by disturbing the structure of the SC
but does not cause epidermal hyperproliferation and inflam-
matory infiltration. Evaluation of SspA-induced injury in
hairless mice with normal immune systems has confirmed
results obtained when nude mice are used as a model of
infection (Hirasawa et al. 2010). Furthermore, analysis by
scanning electron microscopy has shown a reduced abun-
dance of adhesive corneocytes on the skin of mice on which
protease is applied. Based on the high degree of similarity
between the primary and tertiary SspA structures and the
preference of exfoliative toxins for Glu-Xaa peptide bonds,
one can speculate that the epidermal permeability is the
consequence of desmoglein 1 cleavage in corneodesmo-
somes. Disruption of the epithelial barrier by S. aureus
extracellular protease compromises the protective functions
of the skin by allowing the entry of allergens and
microorganisms. A similar effect has been reported for a
cysteine protease of house-dust mites, which impairs the
epidermal permeability barrier, thus enhancing IgE and
IgG responses to penetrating allergens (Kato et al. 2005;
Kikuchi et al. 2006; Nakamura et al. 2006). This can addi-
tionally aggravate allergic reactions attributable to mast cell
activation by infection (McAlpine et al. 2011). Notably, in
this context, S. aureus can subvert the extracellular antimicro-
bial activity of mast cells by promoting its own internalisation
by these cells (Abel et al. 2011).
Once proteolytic enzymes produced by skin pathogens
disrupt the keratynocyte barrier, the underlying tissue layers
can be penetrated by microorganisms and their products.
Recently, the translocation of S. pyogenes (Group A strep-
tococcus, GAS) through damaged skin has been docu-
mented as being facilitated by streptolysin S. This process
is accompanied by the cleavage of transmembrane junction-
al proteins, including E-cadherin. Interestingly, streptolysin
acts in concert with calpain, the host cysteine protease
(Sumitomo et al. 2011).
Elastin is one of the connective tissue components of the
dermis layer. S. aureus secretes two papain-like cysteine
proteases, namely staphopain A (ScpA) and staphopain B
(SspB). ScpA exerts elastinolytic activity comparable with
neutrophil elastase, which might explain the destruction of
connective tissue during staphylococcal infection (Potempa
et al. 1988). Furthermore, recent studies indicate that the
presence of staphopains at concentrations as low as 10 nM
can also degrade collagen (Ohbayashi et al. 2010). S. epi-
dermidis, a predominant inhabitant of human skin, express a
cell-wall-associated cysteine protease Ecp. A homology
search by using the N-terminal sequence has revealed se-
quence similarity to S. aureus ScpA and SspB. Consistent
with this, the Ecp protease also possesses elastinolytic ac-
tivity, which might contribute to the invasiveness and path-
ogenic potential of S. epidermidis (Oleksy et al. 2004).
Elastase, the major metalloproteinase expressed by P.
aeruginosa, degrades proteins on the surface of skin-
derived fibroblasts. Moreover, this enzyme can inhibit fi-
broblast cell growth. These effects, in conjunction with ex
vivo data showing that elastase is present in the fluids of
wounds infected with P. aeuginosa, suggest that bacterial
proteinases play a pathogenic role in chronic ulcers
(Schmidtchen et al. 2003).
Bacterial enzymes also contribute indirectly to tissue
injury by intercepting the functions of tightly regulated host
enzymes. Alternatively, they can release the activity of
endogenous proteases from the control exerted by protein-
ase inhibitors, including cystatins and elafin (Vincents et al.
2007; Guyot et al. 2010). Cystatins regulate skin barrier
formation by inhibiting the activity of cathepsin V, cathepsin
L and legumain, thereby controlling transglutaminase 3
processing. Infringement of this pathway leads to abnormal
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SC and hair follicle formation and a severe malfunction of
the skin barrier probably contributes to the dysregulation
observed in inflammatory dermatoses (Cheng et al. 2009). S.
aureus cysteine proteases ScpA and SspB are not inhibited
by human cystatins; instead, extracellular cystatins C, D and
E/M are hydrolysed by both staphopains (Vincents et al.
2007). Thus, the normal activity of the cystatins is down-
regulated, indicating that bacterial enzymes can alter the
host protease-inhibitor balance. Moreover, the inactivation
of cystatins can lead to the enhancement of cathepsin activ-
ity, which in turn can inactivate AMPs. Despite a broad
range of in vitro and ex vivo results demonstrating the
pathogenic potential of staphopains, their role as important
staphylococcal virulence factors in vivo still needs to be
demonstrated by using appropriate animal models of S.
aureus infection.
Indirect mechanism of proteases action
The host defence system has to cope with various micro-
organisms to obtain equilibrium, otherwise an exacerbated
inflammatory response can lead to tissue injury. Penetration
of bacteria through the skin barrier mobilises a broad range
of host defence mechanisms, such as professional phago-
cytes, the complement system and cytokines. Since bacteria
proteases possess the ability to inactivate, derail or interfere
with these defence mechanisms, they are considered to be
potential virulence factors.
Professional phagocytes Cellular defence involves neutro-
phils and macrophages that infiltrate subepithelial connec-
tive tissues. The critical step that precedes bacterial
engulfment is the recognition of pathogens. The efficiency
of this step is enhanced by bacteria opsonisation with spe-
cific antibodies and/or complements. IdeS is a cysteine
protease of S. pyogenes that allows GAS to evade
antibody-mediated phagocytosis by cleaving IgG at the
lower hinge region. Simultanously, IgGs captured via their
Fc region by immunoglobulin-binding proteins, streptococ-
cal M or M-like proteins on bacterial surfaces are protected
from proteolysis; this allows the formation of a host-like
coat by IgG molecules (Su et al. 2011). Interestingly, cys-
tatin C, a cysteine protease inhibitor, acts as a cofactor that
accelerates IgG cleavage by IdeS (Vincents et al. 2008).
Another strategy aimed at professional phagocytes involves
the use of streptopain (streptococcal pyrogenic exotoxin B,
SpeB) by S. pyogenes (Nelson et al. 2011). SpeB internal-
ised by neutrophils can cause mitochondrial damage man-
ifested by a decrease in dehydrogenase activity and a loss of
membrane potential after r-SpeB treatment. Although the
incubation of neutrophils with the wild-type strain, the speB
mutant, or the r-SpeB protein does not affect the total
number of viable cells, one can argue that professional
phagocyte functions are disabled (Chiang-Ni et al. 2006).
A significant reduction in the number of functional phag-
ocytes at infection sites can be potentially induced by SspB,
the cysteine protease of S. aureus. This effect is exerted by
selective cleavage of CD11b on phagocytes, which rapidly
acquire the features of a dead cell (Smagur et al. 2009a).
Furthermore, exposure of phagocytes to SspB blocks the
phagocytosis of S. aureus by neutrophils, represses their
chemotactic activity and induces extensive non-phlogistic
clearance of SspB-treated cells by macrophages. The latter
effect occurs by the proteolytic degradation of CD31, which
constitutes a repulsive “do not-eat-me” signal on the surface
of leucocytes (Smagur et al. 2009b). Collectively, this may
lead to the depletion of functional neutrophils at infection
sites, thus facilitating staphylococcal colonisation and
spreading in subepithelial tissues.
The intracellular persistence of pathogens in both profes-
sional phagocytes and non-phagocyting cells is supported
by the expression of bacterial proteases. An S. aureus metal-
loprotease, aureolysin, contributes to survival within macro-
phages (Kubica et al. 2008). Following phagocytosis by
human neutrophils, aureolysin is strongly expressed by
engulfed S. aureus, thereby confirming enzyme production
during host-pathogen interaction (Burlak et al. 2007). Ad-
ditionally, in vivo, SpeB appears to contribute to the intra-
cellular survival of S. pyogenes in macrophages during acute
invasive infections (Thulin et al. 2006). Together, the data
make it clear that bacterial proteases can play a role in
protecting bacteria from phagocytes in skin layers infiltrated
by these immune cells.
Complement system The complement system participates in
the immune recognition of foreign antigens, many of which
might penetrate the skin by physical injury or transcutane-
ous adsorption. Pathogens target and subvert the comple-
ment system by degrading or binding complement
components to prevent the activation of the pathway. Since
the C3 and C5 convertase complexes play a pivotal role in
activating the complement system, they are the major targets
of many bacterial proteases (Potempa and Pike 2009).
Recent data indicate that S. aureus aureolysin disables
complement activation by inhibiting the deposition of C3b
on the bacterial surface and the release of the chemoattrac-
tant C5a, practically paralysing all complement-dependent
antibacterial functions. This occurs because aureolysin
cleaves C3, the central complement protein, generating
C3b, which is further degraded by host factors. Thus, aur-
eolysin acts in synergy with host regulators to inactivate C3,
effectively dampening the host immune response (Laarman
et al. 2011). Another skin pathogen, S. pyogenes, prevents
the formation of the C5 convertase complex, since SpeB
efficiently degrades C3 (Kuo et al. 2008; Terao et al. 2008).
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SpeB protease also cleaves properdin, which stabilises the
formation of the C5 convertase complex through an alterna-
tive complement activation pathway (Tsao et al. 2006).
Finally, a specific S. pyogenes enzyme, C5a peptidase (Wex-
ler et al. 1985), disables the complement-dependent influx
of neutrophils to sites infected with S. pyogenes. C5 pepti-
dase strongly contributes to S. pyogenes pathogenicity (Ji et
al. 1996, 1997; Cleary et al. 2004) and might be essential for
protecting streptococci during skin infections. Interestingly,
C5a peptidase expression is upregulated in bacteria by human
serum (Gleich-Theurer et al. 2009).
Cytokine and chemokine network Chemokines are a large
superfamily of cytokines that provide chemotactic activity
for immune cells. Modulation of their activity can occur
upon proteolytic processing at both N- and C-termini. Some
bacterial species, such as S. pyogenes, use proteases to
exploit this mechanism. The S. pyogenes protease ScpC
degrades interleukin-8 (IL-8), a chemokine that mediates
neutrophil transmigration and activation. Bacteria express-
ing ScpC overcome immune clearance by preventing the
recruitment of neutrophils to soft tissue infection in mice
(Sjölinder et al. 2008). Finegoldia magna, a commensal that
is also associated with skin and soft tissue infections, ex-
press subtilisin-like extracellular serine protease (SufA).
SufA is associated with the bacterial cell surface but is also
released in substantial amounts during bacterial growth.
SufA has been found to cleave and inactivate the CXC
chemokine MIG/CXCL9 efficiently, indicating that the en-
zyme promotes F. magna survival and colonisation (Karlsson
et al. 2007). Recently, serine proteases derived from S. aureus
have been found to initiate and maintain the inflammatory
response by modulating IL-8 synthesis and nuclear factor
kappa B (NFκB) activation (Rudack et al. 2009). A similar
effect, i.e. induction of IL-8 secretion, has also been docu-
mented for P. aeruginosa exoprotease LepA (Kida et al.
2008).
Chemerin is a ligand for CMKLR1, a seven transmem-
brane G-protein-coupled receptor. Chemerin circulates as an
inactive precursor (prochemerin) in blood but its cytokine
expression (specific mRNA) has also been detected in skin
(Wittamer et al. 2003). Maturation of chemerin into an
active cytokine requires proteolytic processing. Recently,
active chemerin has been demonstrated to be generated by
the secreted cysteine protease SspB of S. aureus (Kulig et al.
2007). In skin infected with S. aureus, proteolytically pro-
cessed chemerin might therefore contribute to the patholog-
ical inflammatory response by attracting selected
immunoregulatory antigen-presenting cells, such as imma-
ture plasmacytoid dendritic cells (Skrzeczyńska-Moncznik
et al. 2009) and macrophages. The potential in vivo role of
staphopain in chemerin activation correlates with the finding
that S. aureus has been implicated as an aggravating factor
in psoriasis (Kulig et al. 2007). Consistent with this, high
levels of active chemerin have been found in the skin of
psoriatic patients (Skrzeczyńska-Moncznik et al. 2009).
Cell signalling The protease-activated receptors (PARs) are
a family of four G-protein-coupled receptors that are acti-
vated upon enzymatic cleavage at their N-termini by specif-
ic serine proteases. The exposed tethered ligand domains
bind to and activate the cleaved receptors. Four human
members of the family are known: PAR1–4. PAR-1, PAR-
3 and PAR-4 are activated physiologically by thrombin,
whereas PAR-2 activation is associated with a proinflamma-
tory response. PAR-2 is highly expressed in keratinocytes
and might play an important role in cutaneous inflammation.
PARs are targeted by many bacteria-derived proteases (Ima-
mura and Potempa 2011), including enzymes produced by
skin pathogens. LepA, a secreted protease from P. aerugi-
nosa, signals through PAR-1-, PAR-2- and PAR-4-specific
proteolysis and activates the NFκB pathway (Kida et al.
2008). Simultaneously, LasB, an elastynolytic metallopro-
tease from the same bacterium, antagonises the effect of
LepA by degrading and inactivating the receptor (Dulon et
al. 2005). Serratia marcescens, a rare cause of skin infec-
tions, expresses serralysin, which cleaves PAR-2 on HeLa
cells. This leads to the activation of critical transcription
factors AP-1, C/EBPβ and NFκB (Kida et al. 2007). Re-
cently, exogenous proteases from Propionibacterium acnes
have been demonstrated to elicit cellular responses via PAR-
2. Activation of PAR-2 on keratinocytes has been shown to
lead to the induction of proinflammatory cytokines, AMPs
and matrix metalloproteinases (Lee et al. 2010).
Kallikrein/kinin system The contact system is an integral
part of skin innate immunity, which, once activated, delivers
bactericidal peptides derived from kininogens, entraps bac-
teria and stimulates professional phagocytes. Furthermore,
kinins, such as bradykinin (BK) and its metabolite,
desArg9BK, can act as co-mitogens in cellular proliferation
and as proinflammatory factors, which are important for
vascular permeabilisation and pain propagation (Schremmer-
Danninger et al. 1999).
Initially, vascular leakage (VL) supplies antimicrobial
factors (e.g. antibodies, complement factors) and causes
blood leucocyte infiltration, contributing to pathogen elim-
ination. An excessive inflammatory reaction, a consequence
of serious tissue damage, can be induced by bacterial pro-
teases, which play a crucial role in the uncontrolled gener-
ation of proinflammatory mediators. Activation of the
kallikrein-kinin system is initiated by Hageman factor
(HF) activation, followed by the production of kallikrein
from plasma prekallikrein (PK). High molecular weight
kininogen is the substrate for plasma kallikrein, which
releases BK. On the other hand, kallidin is generated from
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low-molecular weight kininogen by tissue kallikrein (Chao
et al. 2010). Kallidinis are ultimately converted to BK
(Cochrane and Griffin 1982; Bhoola et al. 1992).
Bacterial proteases are potent activators of contact system
zymogens (Herwald and Potempa 2011). Alkaline protein-
ase and elastase from P. aeruginosa and metalloproteases
from V. vulnificus activate HF and PK (Molla et al. 1989);
however, only the latter has been described in the human
(Miyoshi and Shinoda 1992). Aeromonas sobria, a faculta-
tive anaerobe that can cause skin infections, expresses serine
proteases (ASP) that induce vascular leakage activity by
specifically activating human PK (Jones and Wilcox 1995;
Imamura et al. 2006).
The release of kinins requires the cleavage of kininogen at
two peptide bonds; this can be achieved directly by bacterial
proteases without PK or HF activation. Bacterial proteases,
such as staphopains from S. aureus or streptopain from S.
pyogenes, are important virulence factors, since they can
potently release kinins from kininogens (Imamura et al.
2005; Herwald et al. 1996). Proteolytically active ScpA has
been found to induce VL in a BK B(2)-receptor-dependent
manner in guinea pig skin. This effect is augmented by SspB,
which, by itself, has no VL activity (Imamura et al. 2005). The
enhancing effect of SspB is attributable to the release of a new
kinin that contains an amino terminus that is extended by three
amino acid residues. Furthermore, plasma leakage spreads in
subcutaneous tissue, since ScpB degrades elastin and other
extracellular matrix proteins (Potempa et al. 1988). A similar
mode of action has been reported for serine protease ASP
secreted by A. sobria, which induces VL activity mainly in a
BK B(2) receptor-dependent manner in guinea pig skin. ASP
produces more VL activity directly from human low-
molecular-weight kininogen than from high-molecular-
weight kininogen (Imamura et al. 2006). Furthermore, ASP
produces far more desArg-BK than BK from kininogens.
DesArg-BK binds to the B1 receptor and responses mediated
by this receptor are upregulated by lipopolysaccharide or
inflammatory cytokines in animal and human tissues
(Marceau et al. 1998). Collectively, the data clearly
show that bacterial proteases play an important role in
the amplification of kinin generation, which can be
associated with the pathophysiology of infectious diseases.
Such tactics can facilitate systemic dissemination of a pathogen
from the initial site of colonisation.
Concluding remarks
Taken together, the above data clearly reveal that proteases
secreted by pathogenic bacteria that colonise damaged skin
play a role in the invasion of deeper skin layers and con-
tribute to the development of a local inflammatory reaction.
This function is in stark contrast to proteases of skin com-
mensal microorganisms, which use their proteases to main-
tain an equilibrium with host defences and homeostasis of
the colonised skin.
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